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Abstract
The robust computational design of functional proteins has the potential to deeply impact
translational research and broaden our understanding of the determinants of protein function
and stability. The low success rates of computational design protocols and the extensive in
vitro optimization often required, highlight the challenge of designing proteins that perform
essential biochemical functions, such as binding or catalysis. One of the most simplistic
approaches for the design of function is to adopt functional motifs in naturally occurring pro-
teins and transplant them to computationally designed proteins. The structural complexity of
the functional motif largely determines how readily one can find host protein structures that
are “designable”, meaning that are likely to present the functional motif in the desired confor-
mation. One promising route to enhance the “designability” of protein structures is to allow
backbone flexibility. Here, we present a computational approach that couples conformational
folding with sequence design to embed functional motifs into heterologous proteins—Rosetta
Functional Folding and Design (FunFolDes). We performed extensive computational bench-
marks, where we observed that the enforcement of functional requirements resulted in
designs distant from the global energetic minimum of the protein. An observation consistent
with several experimental studies that have revealed function-stability tradeoffs. To test the
design capabilities of FunFolDes we transplanted two viral epitopes into distant structural
templates including one de novo “functionless” fold, which represent two typical challenges
where the designability problem arises. The designed proteins were experimentally charac-
terized showing high binding affinities to monoclonal antibodies, making them valuable candi-
dates for vaccine design endeavors. Overall, we present an accessible strategy to repurpose
old protein folds for new functions. This may lead to important improvements on the computa-
tional design of proteins, with structurally complex functional sites, that can perform elaborate
biochemical functions related to binding and catalysis.
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Author summary
The ability to use computational tools to manipulate the structure and function of pro-
teins has the potential to impact many facets of fundamental and translational science.
Due to our limited understanding of the principles that govern protein function and
structure, the computational design of functional proteins remains challenging. We devel-
oped a computational protocol (Rosetta FunFolDes) to facilitate the insertion of func-
tional motifs into heterologous proteins. We performed extensive in silico benchmarks,
and found that when the design of function is required the global energy minima may not
be the optimal solution, in line with previously reported experimental studies. Further, we
used FunFolDes to design two novel functional proteins, displaying two viral epitopes that
can be of interest for vaccine development. The designed proteins were experimentally
characterized, showing that functionalization was successfully achieved. These results
highlight the capability of FunFolDes to address common challenges on the design of
functional proteins. In particular, the reduced structural compatibility between functional
sites and host scaffolds, effectively enabling the repurposing of old protein folds for new
functions. Overall, FunFolDes provides new means to accomplish the challenging task of
functionalizing computationally designed proteins.
Introduction
Proteins are one of the main functional building blocks of the cell. The ability to create novel
proteins outside of the natural realm has opened the path towards innovative achievements,
such as new pathways [1], cellular functions [2], and therapeutic leads [3–5]. Computational
protein design is the rational and structure-based approach to solve the inverse folding prob-
lem, i.e. the search for the best putative sequence capable of fitting and stabilizing a protein’s
three-dimensional conformation [6]. As such, a great deal of effort has been placed into under-
standing the rules of protein folding and stability [7, 8] and its relation to the appropriate
sequence space [9].
Computational protein design approaches focus on exploring two interconnected land-
scapes related to sampling of the conformational and sequence spaces. Fixed backbone
approaches use static protein backbone conformations, which greatly constrain the sequence
space explored by the computational algorithm [9]. Following the same principles of naturally
occurring homologs, which often exhibit confined structural diversity, flexible backbone
approaches enhance the sequence diversity, adding the challenge of identifying energetically
favorable sequence variants that are correctly coupled to structural perturbations [10].
Another variation for computational design approaches is de novo design, in which protein
backbones are assembled in silico, followed by sequence optimization to fold into a pre-defined
three-dimensional conformation without being constrained by previous sequence information
[11–13]. This approach tests our understanding of the rules governing the structure of differ-
ent protein folds. The failures and successes of this approach confirm and correct the princi-
ples used for the protein design process [7, 8].
One of the main aims of computational protein design is the rational design of functional
proteins capable of carrying existing or novel functions into new structural contexts [14].
Broadly, there are three main approaches for the design of functional proteins: redesigning of
pre-existing functions, grafting of functional sites onto heterologous proteins, and designing
of novel functions not found in the protein repertoire. The redesign of a pre-existing function
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to alter its catalytic activity [15] or improve its binding target recognition [16] can be consid-
ered the most conservative approach. It is typically accomplished by point mutations around
the functional area of interest and tends to have little impact on global structure of the
designed protein. On the other extreme, the design of fully novel functions has most noticeably
been achieved by applying chemical principles that tested our fundamental knowledge of
enzyme catalysis [17, 18].
Between these two approaches resides protein grafting. This method aims to repurpose nat-
ural folds as carriers for exogenous known functions. It relies on the strong structure-function
relationship present in proteins, to endow an heterologous protein with an exogenous function
by means of transferring a structural motif that performs such function [3–5, 19–22].
At the biochemical level, grafting approaches have been used to design high binding affinity
protein-protein interactions, by stabilizing binding motifs removing the entropic cost of bind-
ing (e.g. flexible peptides) [21], and also by extending the binding interfaces to allow for addi-
tional energetically favorable interactions. The extended interfaces also provide opportunities
to tune the specificity of the designed proteins [21]. On the practical side, some of the most
notable applications of protein grafting thus far, have been the design of novel viral inhibitors
[21, 23] and epitope-focused immunogens for vaccine design [3–5]. Following this strategy
one can easily imagine applications to functionalize protein-based biomaterials [24] or to
design novel biosensors [25]. The importance of robust grafting approaches to functionalize
heterologous proteins is related to the fact that the proteins that naturally perform these func-
tions, may lack the best biochemical properties in terms of size, affinity, solubility, immunoge-
nicity and other application specific factors.
Thus far, the most successful grafting approaches are highly dependent on structural simi-
larity between the functional motif and the insertion region in the protein scaffold. When the
functional motif and the insertion region are identical in backbone conformation, the motif
transfer can be performed by side-chain grafting, i.e. mutating the target residues into those of
the functional motif [3, 5]. In much more challenging scenarios, full backbone grafting may be
used in conjunction with directed evolution [19]. Nevertheless, motif transfer is limited
between very similar structural regions, which greatly constrains the subset of putative scaf-
folds that can be used for this purpose. The lack of compatibility between the putative scaffolds
and the functional sites has been referred to as a “designability” problem [26, 27], which refers
to the likelihood of a protein backbone to host and stabilize a structural motif. The designabi-
lity problem becomes more obvious as the structural complexity of the functional motif grows,
drastically limiting the types of functional motifs that can be transferred. Previously, we have
demonstrated the possibility of expanding protein grafting to scaffolds with segments that
have low structural similarity. To accomplish that task, we developed the prototype protocol
Rosetta Fold From Loops (FFL) [4, 21].
The distinctive feature of our protocol is the coupling of the folding and design stages to
bias the sampling towards structural conformations and sequences that stabilize the grafted
functional motif. In the past, FFL was used to obtain designs that were functional (synthetic
immunogens [4] and protein-based inhibitors [21]) and where the experimentally determined
crystal structures closely resembled the computational models. However, the structures of the
functional sites were structurally very close to the insertion segments of the hosting scaffolds.
The architecture of FFL was intrinsically limited in the types of constraints available and the
grafting of linear, single segment functional motifs.
Here, we present a complete re-implementation of FFL with enhanced functionalities, sim-
plified user interface and complete integration with other Rosetta protocols. We have called
this new, more generalist protocol Rosetta Functional Folding and Design (FunFolDes). We
benchmarked FunFolDes extensively, unveiling important technical details to better exploit
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PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1006623 November 19, 2018 3 / 30
and expand the capabilities of the protocol. Furthermore, we challenged FunFolDes with two
design tasks of transplanting viral epitopes to heterologous scaffolds, and by doing so probe
the applicability of the protocol. The design tasks were centered on using distant structural
templates as hosting scaffolds, and functionalizing a de novo designed protein,—FunFolDes
succeeded in both challenges. These results are encouraging and provide a solid basis for the
broad applicability of FunFolDes as a strategy for the robust computational design of functio-
nalized proteins.
Results
Rosetta FunFolDes–a computational framework for design of functional
proteins
The original prototype of the Rosetta Fold From Loops (FFL) protocol was successfully used to
transplant the structural motif of the Respiratory Syncytial Virus protein F (RSVF) site II neu-
tralizing epitope into a protein scaffold in the context of a vaccine design application [4].
FFL enabled the insertion and conformational stabilization of the structural motif into a
defined protein topology by using Rosetta’s fragment insertion machinery to fold an extended
polypeptide chain to adopt the desired topology [28] which was then sequence designed. Informa-
tion from the scaffold structure was used to guide the folding, ensuring an overall similar topology
while allowing for the conformational changes needed to stabilize the inserted structural motif.
The final implementation of FunFolDes is schematically represented in Fig 1, and fully
described in Materials and Methods. Our upgrades to FFL focused on three main aims: I)
improve the applicability of the system to handle more complex structural motifs (i.e. multiple
discontinuous backbone segments); II) enhance the design of functional proteins by including
binding partners in the simulations; III) increase the control over each stage of the simulation
improving the usability for non-experts. These three aims were achieved through the imple-
mentation of five core technical improvements described below.
Insertion of multi-segment functional sites. Most functional sites in proteins typically
entail, at the structural level, multiple discontinuous segments, as is the case for protein-pro-
tein interfaces, enzyme active-sites, and others [29, 30]. FunFolDes handles functional sites
with any number of discontinuous segments, ensuring the native orientations of each of the
segments. These new features enhance the types of structural motifs that can be handled by
FunFolDes, widening the applicability of the computational protocol.
Structural folding and sequence design in the presence of a binding target. Many of the
functional roles of proteins in cells require physical interaction with other proteins, nucleic
acids, or metabolites [31]. The inclusion of the binder has two main advantages: I) explicit
representation of functional constraints to bias the designed protein towards a functional
sequence space, resolving putative clashes derived from the template scaffold; II) facilitate the
design of new additional contact residues (outside of the motif) that may afford enhanced
affinity and/or specificity.
Region-specific structural constraints. FunFolDes can collect from full-template to
region-specific constraints, allowing greater levels of flexibility in areas of the scaffold that can
be critical for function (e.g. segments close to the interface of a target protein). The type of dis-
tance constrains used in the protocol are soft constrains with score penalties if the defined
standard deviation is exceeded in the upper and lower bounds. Furthermore, FunFolDes is no
longer limited to atom-pair distance constraints [32] and can incorporate other types of kine-
matic constraints, such as angle and dihedral constraints [33], which have been used exten-
sively to design beta-rich topologies [8].
Computational design of functional proteins with Rosetta FunFolDes
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Fig 1. Rosetta FunFolDes—Method overview. FunFolDes was devised to tackle a wide range of functional protein design problems,
combining a higher user control of the simulation parameters whilst simultaneously lowering the level of expertise required. FunFolDes is able
to transfer single- and multi-segment motifs (light blue) together with the target partner (grey) by exploiting Rosetta’s FoldTree framework (top
row). A wider range of information can be extracted from the template (wheat) to shift the final conformation towards a more productive
design space (middle row), including targeted distance constraints, generation of structure-based fragments, motif insertion in sites with
different residue length and presence of the binding target to bias the folding stage. The bottom row showcases the most typical application of
the FunFolDes protocol. Implementation in RosettaScripts allows to tailor FunFolDes behavior. A seamless integration with other protocols
and complex selection logics can be added to address the different needs in each design task.
https://doi.org/10.1371/journal.pcbi.1006623.g001
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On-the-fly fragment picking. Classically, fragment libraries are generated through
sequence-based predictions of secondary structure and dihedral angles that rely on external
computational methods [34]. We leveraged internal functionalities in Rosetta so that Fun-
FolDes can assemble fragment sets on-the-fly. Using this feature, we can assemble fragment
sets based on the structure of the input scaffold. Sequence-based fragments remain an option,
however this feature removes the need for secondary applications, boosting the usability of
FunFolDes. Lastly, the on-the-fly fragment picking enables the development of protocols with
mutable fragment sets along the procedure.
Compatibility with other Rosetta modules. Finally, FunFolDes is compatible with Roset-
ta’s modular xml-interface—Rosetta Scripts (RS) [35]. Enabling customization of the Fun-
FolDes protocol and, more importantly, cross-talk with other protocols and filters available
through the RS interface.
We devised two benchmark scenarios to test the performance of FunFolDes. One of these
aimed to capture conformational changes in small protein domains caused by sequence inser-
tions or deletions, and the second scenario assessed protocol performance to fold and design a
binder in the presence of the binding target.
Capturing conformational and sequence changes in small protein domains
Typical protein design benchmarks are assembled by stripping native side chains from known
protein structures and evaluating the sequence recovery of the design algorithm [9]. The main
design aim of FunFolDes is to insert structural motifs into protein folds while allowing flexibil-
ity across the overall structure. This conformational freedom allows the full protein scaffold to
adapt and stabilize the functional motif’s conformation. This is a main distinctive point from
other approaches to design functional proteins that rely on a mostly rigid scaffold [2, 3, 11, 19,
30, 36]. For many modeling problems, such as protein structure prediction, protein-protein
and protein-ligand docking, and protein design, standardized benchmark datasets are avail-
able [37] or easily accessible. Devising a benchmark for designed proteins with propagating
conformational changes across the structure is challenging, as we are assessing both structural
accuracy as well as sequence recovery of the protocol.
To address this problem, we analyzed structural domains found repeatedly in natural pro-
teins and clustered them according to their definition in the CATH database [38]. As a result,
we selected a set of 14 benchmark targets labeled T01 through T14 (Fig 2A). A detailed descrip-
tion on the construction of the benchmark can be found in the Materials and Methods section.
Briefly, for the benchmark we selected proteins with less than 100 residues, where each test
case was composed of two proteins of the same CATH domain cluster. One of the proteins is
the template, and serves as a structural representative of the CATH domain. The second pro-
tein, dubbed target, contains structural insertions or deletions (motif region), to which a struc-
tural change in a different segment of the protein could be attributed (query region). The
motif and query regions for all the targets are shown in Fig 2A and quantified by the percent-
age of overall secondary structure in S1A Fig. To a great extent, these structural changes due
to natural sequence insertions and deletions are analogous to those occurring in the design
scenarios for which FunFolDes was conceived.
Using FunFolDes, we folded and designed the target proteins while maintaining the motif
segment structurally fixed, mimicking a structural motif insertion. Distance constraints
between residues were extracted from the template in the regions of shared structural elements
of the template and the target, and were used to guide the folding simulations.
To check whether FunFolDes enhances sequence and structural sampling, we compared
the simulations to constrained ab initio (cst-ab initio) simulations [33]. As Rosetta
Computational design of functional proteins with Rosetta FunFolDes
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conformational sampling is highly dependent upon the fragment set [39], in this benchmark
we also tested the influence of structure- and sequence-based fragments. The performance of
the two protocols was analyzed regarding global and local recovery of both structure and
sequence.
Fig 2. Benchmark test set to evaluate FunFolDes structural sampling. A) Structural representation of the 14 targets used in the benchmark. In each target is
highlighted the motif (red) and query (blue) regions, and the positions from which distance constraints were generated (light blue). Conformations of the motif and
query regions, as found in the template structures, are shown superimposed in light grey. B) Full structure RMSD (Overall RMSD) and local RMSD for the query region
(FunFolDes–Query Region) is presented for four targets (full dataset presented in S1 Fig). Overall RMSD compares results for the two simulation modes (FunFolDes Vs.
constrained–ab initio (cst-ab initio)) and the two fragment generation methods (structure (blue) Vs. sequence-based fragments (green)) against their original target.
FunFolDes more frequently samples RMSDs closer to the conformation of the target structure. Generally, structure-based fragments contribute to lower mean overall
RMSDs. The FunFolDes–Query Region RMSD distributions show that the two fragment sets do not have a major importance in the structural recovery of the query
region.
https://doi.org/10.1371/journal.pcbi.1006623.g002
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Structural recovery was assessed through two main metrics: (a) global RMSD of the full
decoys against the target and (b) local RMSD of the query region. When evaluating the distri-
butions for global RMSD in the designed ensembles, FunFolDes outperformed cst-ab initio by
consistently producing populations of decoys with lower mean RMSD (mostly found below 5
Å), a result observed in all 14 targets (Fig 2B, S1B Fig). This result is especially reassuring con-
sidering that FunFolDes simulations contain more structural information of the target topol-
ogy than the cst-ab initio simulations.
The local RMSDs of the query unconstrained regions presented less clear results across the
benchmark (S1B Fig). In 13 targets, FunFolDes outperformed cst-ab initio, showing lower
mean RMSDs but in some targets with minor differences.
When comparing fragment sets (structure- vs sequence-based), both achieved similar mean
RMSDs in the decoy populations; nonetheless, the structure-based fragments more often
reached the lowest RMSDs for overall and query RMSDs (Fig 2B, S1 Fig). This is consistent
with what would be expected from the structural information content within each fragment
set. When paired with the technical simplicity of use, time-saving and enhanced sampling of
the desired topology, the structure-based fragments are an added value for FunFolDes.
We also quantified sequence recovery, both in terms of sequence identity and similarity
according to the BLOSUM62 matrix [40] (Fig 3A). In all targets, FunFolDes showed superior
recoveries than cst-ab initio, and at the levels of other design protocols using Rosetta [10] (Fig
3A). This type of metrics has been shown to be highly dependent on the exact backbone con-
formation used as input [9, 10]. Given that FunFolDes is exploring larger conformational
spaces, as a proxy for the quality of the sequences generated, we used the target’s Hidden Mar-
kov Models (HMM) [41] and quantified the designed sequences that were identified as part of
the target’s CATH superfamily according to its HMM definition (Fig 3B). FunFolDes decoy
populations systematically outperformed those from cst-ab initio (Fig 3B). The performance
of the two fragment sets shows no significant differences.
In summary, this benchmark highlights the ability of FunFolDes to generate close-to-native
scaffold proteins to stabilize inserted structural motifs. FunFolDes aims to refit protein scaf-
folds towards the structural requirements of a functional motif. It is thus critical, to explore
within certain topological boundaries, structural variations around the original templates. This
benchmark points to several variables in the protocol that resulted in enhanced structural and
sequence sampling.
Target-biased folding and design of protein binders
The computational design of proteins that can bind with high affinity and specificity to targets
of interest remains a largely unsolved problem [42]. Within the FunFolDes conceptual
approach of coupling folding with sequence design, we sought to add the structure of the bind-
ing target (Fig 1) to attempt to bias sampling towards functional structural and sequence
spaces.
Previously, we used FFL to design a new binder (BINDI) to BHRF1 (Fig 4A), an Epstein-
Barr virus protein with anti-apoptotic properties directly linked to the tumorigenic activity of
EBV [21]. FFL designs bound to BHRF1 with a dissociation constant (KD) of 58–60 nM, and
after affinity maturation reached a KD of 220±50 pM. BINDI was designed in the absence of the
target and then docked to BHRF1 through the known interaction motif. A striking observation
from the overall approach was that the FFL stage was highly inefficient, generating a large frac-
tion of backbone conformations incompatible with the binding mode of the complex.
To test whether the presence of the target could improve structural and sequence sampling,
we leveraged the structural and sequence information available for the BINDI-BHRF1 system
Computational design of functional proteins with Rosetta FunFolDes
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and benchmarked FunFolDes for this design problem. As described by Procko and colleagues,
when comparing the topological template provided to FFL and the BINDI crystal structure,
the last helix of the bundle (helix 3) was shifted relative to the template ensuring structural
compatibility between BINDI and BHRF1 (Fig 4B). We used this case study to assess the capa-
bilities of FunFolDes to sample closer conformations to those observed in the BINDI-BHRF1
crystal structure. In addition, we used the saturation mutagenesis data generated for BINDI
[21] to evaluate the sequence space sampled by FunFolDes.
A detailed description of this benchmark can be found in the Materials and Methods sec-
tion. Briefly, we performed four different FunFolDes simulations: I) binding target absent
(no_target); II) binding target present with no conformational freedom (static); III) binding
target present with side-chain repacking (pack); IV) binding target present with side-chain
repacking plus minimization and backbone minimization (packmin).
Fig 3. Assessment of FunFolDes sequence sampling quality. A) HMM Sequence Recovery measures the percentage
of decoys generated that can be assigned to the original HMM from the CATH superfamily. FunFolDes consistently
outperforms cst–ab initio, in agreement with the structural recovery metrics. B) Core Residues Sequence Recovery
shows the sequence recovery between the core residues of the designs set and the target. Recovery is measured in terms
of sequence identity and sequence similarity (as assigned through BLOSUM62). Core sequence identity and similarity
was assessed over the structure-based fragment set. According to this metric FunFolDes outperforms cst-ab initio in
every instance, reaching for some populations, levels of conservation similar to those found in more restrained flexible-
backbone design approaches [10].
https://doi.org/10.1371/journal.pcbi.1006623.g003
Computational design of functional proteins with Rosetta FunFolDes
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Fig 4. Target-biased design of a protein binder and performance assessment based on saturation mutagenesis. A) Depiction of the initial design task, a single-
segment binding motif (BIM-BH3) shown in light blue cartoons, with its target (BHRF1) shown in gray surface, is used by FunFolDes to generate an ensemble of
designs compatible with the binding mode shown in light orange cartoons. B) Conformational difference between the initial template (PDB ID: 3LHP), shown in light
brown and the previously designed binder (BINDI), shown in violet cartoons, helix 3 requires a subtle but necessary shift (2.6 Å) to avoid steric clashes with the target.
C-G) Scoring metrics for design populations according to the simulation mode: no_target—FunFolDes was used without the target protein; static—target present no
flexibility allowed; pack—target allowed to repack the side-chains; packmin–side-chain repacking plus minimization and backbone minimization were allowed for the
target. The target flexibility was allowed during the relax-design cycles of FunFolDes. C) Structural drift observed for design and target binder measured as the RMSD
between pre- and post-minimization conformations. D) Structural recovery of the conformation observed in the BINDI-BHRF1 assessed over the 3 helical segments of
the bundle. E) Rosetta energy for the designs in the unbound state generated by different simulation modes. F) Interaction energy (ΔΔG) between the designs and the
target. G) Deep-sequencing score distribution for each design population, computed as the mean score of each sequence after applying a position score matrix based on
the deep-sequencing data. The pack population slightly outperforms the other simulation modes. H) Per-residue scoring comparison of the no_target and the pack
populations according to the deep-sequencing data. Although the behavior is overall similar, pack outperforms no_target in multiple positions, several of which are
highlighted (black dots) as interfacial contacts or second shell residues close to the binding site.
https://doi.org/10.1371/journal.pcbi.1006623.g004
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no_target simulations generated a low number of conformations compatible with the target
(<10% of the total generated designs) (S2A Fig). Upon global minimization more than 60%
(S2A Fig) of the decoys were compatible with the binding target, at the cost of considerable
structural drifts for both binder (mean RMSD 3.3 Å) and target (mean RMSD 7.7 Å) (Fig 4C).
These structural drifts reflect the energy optimization requirements by the relaxation algo-
rithms but are deemed biologically irrelevant due to the profound structural reconfigurations.
In contrast, simulations performed in the presence of the target clearly biased the sampling to
more productive conformational spaces. RMSD drifts upon minimization were less than 1 Å
for both designs and binding target (Fig 4C).
Global structural alignments of the designs fail to emphasize the differences of the helical
arrangements (S2B Fig). Thus, we aligned all the designs on the conserved binding motif (Fig
4A) and measured the RMSD over the three helices that compose the fold. FunFolDes simula-
tions in the presence of the target sampled a mean RMSD of 3 Å (lowest� 2 Å) compared to
the BINDI structure (Fig 4D), with the closest designs at approximately 2 Å, while the no_tar-
get simulation showed a mean RMSD of 4.5 Å (lowest� 2.5 Å). While we acknowledge that
these structural differences are modest, the data suggests that they can be important to sample
conformations and sequences competent for binding.
We also analyzed Rosetta energy distributions of designs in the unbound state for the differ-
ent simulations. We observed noticeable differences for the designs generated in the absence
(no_target) and the presence of the binding target, -320 and -280 Rosetta Energy Units
(REUs), respectively (Fig 4E). This difference is significant, particularly for a small protein
(116 residues). We also observed considerable differences for the binding energies (ΔΔG) of
the no_target and the bound simulations with mean ΔΔGs of -10 and -50 REUs, respectively
(Fig 4E).
The energy metrics provide interesting insights regarding the design of functional proteins.
Although the sequence and structure optimization for the designs in the absence of the target
reached lower energies, these designs are structurally incompatible with the binding target
and, even after refinement, their functional potential (as assessed by the ΔΔG) is not nearly as
favorable as those performed in the presence of the binding target (Fig 4F). These data suggest
that, in many cases, to optimize function it may be necessary to sacrifice the overall computed
energy of the protein, a common proxy to the experimental thermodynamic stability of the
protein [43]. The existence of stability-function tradeoffs has been the subject of many experi-
mental studies [44, 45], however, it remains a much less explored strategy in computational
design, where it may also be necessary to design proteins with lower stability to ensure that the
functional requirements can be accommodated. This observation provides a compelling argu-
ment to perform biased simulations in the presence of the binding target, which can be broadly
defined as a “functional constraint”.
To evaluate sequence sampling quality, we compared the computationally designed
sequences to a saturation mutagenesis dataset available for BINDI [21].
The details of the dataset and scoring scheme can be found in the methods and S2 Fig.
Briefly, point mutations beneficial to the binding affinity to BHRF1 have a positive score, dele-
terious mutants a negative score, and neutral score 0. Such a scoring scheme, will yield a score
of 0 for the BINDI sequence.
Designs performed in the presence of the binding target obtained higher mean scores as
compared to the no_target designs (Fig 4G). The pack simulation, showed the highest distribu-
tion mean, having one design scoring better than the BINDI sequence. In some key positions
at the protein-protein interface, the pack designs clearly outperformed those generated by the
no_target simulation, when quantified by a per-position score (Fig 4H); meaning that amino-
acids productive for binding interactions were sampled more often. This benchmark provides
Computational design of functional proteins with Rosetta FunFolDes
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an example of the benefits of using a “functional constraint” (binding target) to improve the
quality of the sequences obtained by computational design.
Overall, the BINDI benchmark provided important insights regarding the best FunFolDes
protocol to improve the design of functional proteins.
Repurposing a naturally occurring fold for a new function
To further test FunFolDes’s design capabilities, we sought to transplant a contiguous viral epi-
tope that is recognized by a monoclonal antibody with high affinity (Fig 5A). For this design,
we used the RSVF site II epitope (PDB ID: 3IXT [46]) as the functional motif. This epitope
adopts a helix-loop-helix conformation recognized by the antibody motavizumab (mota) [46].
In previous work we have designed proteins with this epitope, but started from a structurally
similar template, where the RMSD between the epitope and the scaffold segment was
Fig 5. Functional design of a distant structural template. A) Structural representation of 1kx8. The insertion region is colored in light red and the two disulfide
bonds are labeled (CYD). B) Structural comparison between the insertion region of 1kx8 and the site II epitope (light red-filled silhouette). The local RMSD between
the two segments is 2.37 Å. C) Superposition between 1kx8_d2 design model (blue with red motif) and the 1kx8 template (wheat and light red insertion site). Multiple
conformational shifts are required throughout the structure to accommodate the site II epitope. D) CD spectrum of 1kx8_d2 showing a typical alpha-helical pattern
with the ellipticity minima at 208 nm and 220 nm. E) 1kx8_d2 shows a melting temperature (Tm) of 43.4˚C. F) Binding affinity determined by SPR. 1kx8_d2 shows a
KD of 1.14 nM. Experimental sensorgrams are shown in black and the fitted curves in red. G) Per-position evaluation of structural (top) and sequence (bottom)
divergence between the design model 1kx8_d2 and the starting template 1kx8. The largest structural differences are observed in the epitope insertion region, the overall
difference of the two structures is 2.25 Å (dashed line). The sequence was evaluated using the BLOSUM62 score matrix, yielding a total of 13.5% identity and 38.5%
similarity. The epitope region is colored in light red. Identical positions between the 1kx8_d2 and 1kx8 are labeled with the residue one letter code, while positively
scored changes are labeled with plus (+).
https://doi.org/10.1371/journal.pcbi.1006623.g005
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approximately 1 Å over the helical residues. Here, we sought to challenge FunFolDes by using
a distant structural template where the local RMSDs of the epitope and the segment onto
which it was transplanted were higher than 2 Å. We used MASTER [47] to perform the struc-
tural search (detailed description in Materials and Methods) and selected as template scaffold
the structure of the A6 protein of the Antennal Chemosensory system from the moth Mames-
tra brassicae (PDB ID: 1KX8 [48])(Fig 5A). The backbone RMSD between the conformation
of the epitope and the insertion region in 1kx8 is 2.37 Å (Fig 5B).
The A6 protein is involved in chemical communication and has been shown to bind to
fatty-acid molecules with hydrophobic alkyl chains composed of 12–18 carbons. Two promi-
nent features are noticeable in the structure: two disulfide bonds (Fig 5A) and a considerable
void volume in the protein core (S3 Fig), thought to be the binding site for fatty acids. These
features emphasize that the initial design template is likely not a very stable protein.
In the design process we performed two stages of FunFolDes simulations to obtain a proper
insertion of the motif in the topology (Fig 5C). A detailed description of the workflow and
metrics used for selection (S3 Fig) can be found in the Materials and Methods. A striking fea-
ture of our designs, when compared to the starting template, is that they had a much lower
void volume, showing that FunFolDes generated structures and sequences that yielded well
packed structures (S3 Fig).
We started by testing experimentally seven designs. Those that expressed in bacteria were
further characterized using size exclusion chromatography coupled to a multi-angle light scat-
ter (SEC-MALS) to determine the solution oligomerization state. To assess their folding and
thermal stability (Tm) we used Circular Dichroism (CD) spectroscopy, and finally to assess
their functional properties we used surface plasmon resonance (SPR) to determine binding
dissociation constants (KDs) to the mota antibody. Out of the seven designs, six were purified
and characterized further. The majority of the designs were monomers in solution and showed
CD spectra typical of helical proteins. Regarding, thermal stabilities we obtained designs that
were not very stable and did not unfold cooperatively (1kx8_02), however we also obtained
very stable designs that did not fully unfold under high temperatures (1kx8_07) (S4 Fig).
The determined binding affinities to mota ranged from 34 to 208 nM, which was an
encouraging result. Nevertheless, compared to the peptide epitope (KD = 20 nM) and other
designs previously published (KD = 20 pM) [4], there was room for improvement. Therefore,
we generated a second round of designs to attempt to improve stability and binding affinities.
Driven by the observation that the native fold has two disulfide bonds, in the second round,
we tested eight designed variants with different disulfide bonds and, if necessary, additional
mutations to accommodate them. The disulfide bonded positions were selected according to
the spatial orientation of residues in the designed models, with most of the disulfide bonds
being placed at distal locations from the epitope (>20 Å). All eight designs were soluble after
purification and two were monomeric: 1kx8_d2 and 1kx8_3_d1, showing CD spectra typical
of helical proteins (Fig 5D) with melting temperatures (Tms) of 43 and 48˚C (Fig 5E), respec-
tively. Remarkably, 1kx8_d2 showed a KD of 1.14 nM (Fig 5F), an improvement of approxi-
mately 30-fold compared to the best variants of the first round. 1kx8_d2 binds to mota with
approximately 20-fold higher affinity than the peptide-epitope (KD� 20 nM), and 50-fold
lower compared to previously designed scaffolds (KD = 20 pM) [4]. This difference in binding
is likely reflective of how challenging it can be to accomplish the repurposing of protein struc-
tures with distant structural similarity.
Post-design analyses were performed to compare the sequence and structure of the best
design model with the initial template. The global RMSD between the two structures is 2.25 Å.
Much of the structural variability arises from the inserted motif, while the surrounding seg-
ments adopt a configuration similar to the original template scaffold. The sequence identity of
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1kx8_d2 as compared to the native protein is approximately 13%. The sequence conservation
per-position (Fig 5G) was evaluated through the BLOSUM62 matrix, where positive scores are
attributed to the original residue or favorable substitutions and negative if unfavorable. Over-
all, 38.5% of the residues in 1kx8_d2 scored positively, and 61.4% of the residues had a score
equal or lower than 0. This is particularly interesting, from the perspective that several resi-
dues, unfavorable according to BLOSUM62, yielded well folded and functional proteins. To
further substantiate our experimental results, we performed structure prediction simulations
of the designed sequences, where we observed that 1kx8_d2 presents a higher folding propen-
sity than the WT protein (S5A Fig). To evaluate if the predicted models presented the correct
epitope conformation, we performed docking simulations and observed that they obtained
lower binding energies than the native peptide-antibody complex, within similar RMSD fluc-
tuations (S5A Fig).
The successful design of this protein is a relevant demonstration of the broad usability of
FunFolDes and the overall strategy of designing functional proteins by coupled folding and
design to incorporate functional motifs in unrelated protein scaffolds.
Functionalization of a functionless fold
Advances in computational design methodologies have achieved remarkable results in the
design of de novo protein sequences and structures [7, 8, 11]. However, the majority of the
designed proteins are “functionless” and were designed to test the performance of computa-
tional algorithms for structural accuracy. Here, we sought to use one of the hallmark proteins
from de novo design efforts–TOP7 [13] (Fig 6A)–and functionalize it using FunFolDes. The
functional site selected to insert into TOP7 was a different viral epitope from RSVF, site IV,
which is recognized by the 101F antibody [49]. When bound to the 101F antibody, site IV
adopts a β-strand-like conformation (Fig 6B), which in terms of secondary structure content
is compatible with one of the edge strands of the TOP7 topology (Fig 6C). Despite the second-
ary structure similarity, the RMSD of the site IV backbone in comparison with TOP7 is 2.1 Å
over 7 residues, and the antibody orientation in this particular alignment reveals steric clashes
with TOP7. Therefore, this design challenge is yet another prototypical application for Fun-
FolDes, and we followed two distinct design routes: I) a conservative approach where we fixed
the amino-acid identities of roughly half of the core of TOP7 and allowed mutations mostly on
the contacting shell of the epitope insertion site; and II) a sequence unconstrained design
where all the positions of the scaffold were allowed to mutate. We attempted five designs for
recombinant expression in E. coli and two (TOP7_full and TOP7_partial) were selected for
further biochemical and biophysical characterization, one from each of the two design strate-
gies mentioned above. According to SEC-MALS, both behaved as monomers in solution, with
TOP7_partial showing higher aggregation propensity. Both TOP7_full and TOP7_partial (S6
Fig) were folded according to CD measurements. TOP7_full showed a CD spectrum (Fig 6D)
very similar to that of native TOP7 [13]. We observed that TOP7_full was much less stable
than the original TOP7 (Fig 6E)(Tm = 54.5˚C). To quantify the functional component of
TOP7_full, we determined a KD of 24.2 nM with 101F (Fig 6F), within the range measured for
the native viral protein RSVF (3.6 nM) [49]. Importantly, the KD for TOP7_full is 2400 fold
lower than that of the peptide-epitope (58.4 μM) [49], suggesting that productive conforma-
tional stabilization and/or extra contacts to the scaffold were successfully designed.
Per-residue structural similarity and sequence recovery were evaluated for TOP7_full
against TOP7 (Fig 6G). Most conformational changes occur on the site IV insertion region
and displacement of the neighboring alpha-helix, with the overall backbone RMSD being
1.5 Å.
Computational design of functional proteins with Rosetta FunFolDes
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1006623 November 19, 2018 14 / 30
Remarkably, the sequence identity of the most aggressive design (TOP7_full) is only 28%,
and using the BLOSUM62 based scoring system, we observe that most of the TOP7_full resi-
dues were actually favorable, obtaining positive scores. This low conservation is especially rele-
vant considering that intensive studies on TOP7 have revealed the importance of beta-sheet
conservation in order to keep its foldability [22, 50, 51]. Sequence folding prediction experi-
ments showed that TOP7_full has a similar folding propensity to TOP7 and docking simula-
tions also show lower binding energies as compared to the native peptide-antibody complex,
reinforcing the experimental results obtained (S5B Fig),
In summary, our results show that FunFolDes repurposed a functionless protein by folding
and designing its structure to harbor a functional site, which in this case was a viral epitope.
Previously, these computationally designed proteins with embedded viral epitopes were
dubbed epitope-scaffolds and showed their medical applicability as immunogens that elicited
viral neutralizing antibodies [4].
Fig 6. Functionalization of the functionless de novo fold TOP7. A) Structure of TOP7 with the insertion region highlighted in light red. B) Structural comparison
between 101F and TOP7’s insertion region shows a 2.1 Å RMSD. C) TOP7_full model (in blue and red for the motif) superimposed over the TOP7 crystal structure.
101F’s insertion is structurally compensated mostly by the first pairing beta strand and a shift of the first alpha helix. D) CD spectrum shows a broad ellipticity signal
between 210 nm and 222 nm as a representative of mixed alpha and beta secondary structures. E) The Tm for TOP7_full was 54.5˚C. F) Binding affinity determined by
SPR. TOP7_full shows a KD of 24.2 nM. Experimental sensorgrams are shown in black and the fitted curves in red. G) Per-position evaluation of structural (top) and
sequence (bottom) divergence between the design model TOP7_full and the starting template TOP7. The largest structural differences are observed in the region
downstream of the site IV epitope, the overall difference of the two structures is 1.5 Å (dashed horizontal line). The connecting loop between the strand that holds the
epitope and the adjacent strand was also shortened to obtain a tighter connection between the 2 strands (dashed vertical region). Sequence divergence is evaluated by
applying the BLOSUM62 score matrix to the sequences, yielding a total of 27.7% identity and 52.2% similarity. The epitope region is colored in light red. Identical
positions between the TOP7_full and TOP7 are displayed as their residue types while positively scored changes according to BLOSUM62 are labeled with a plus (+).
https://doi.org/10.1371/journal.pcbi.1006623.g006
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Discussion
The robust computational design of proteins that bear a biochemical function remains an
important challenge for current methodologies. The ability to consistently repurpose old folds
for new functions or the de novo design of functional proteins could bring new insights into
the determinants necessary to encode function into proteins (e.g. dynamics, stability, etc.), as
well as, important advances in translational applications (e.g. biotechnology, biomedical, bio-
materials, etc.).
Here, we present Rosetta FunFolDes, that was conceived to embed functional motifs into
protein topologies. This protocol allows for a global retrofitting of the overall protein topology
to favorably host the functional motif and enhance the designability of the starting structural
templates. FunFolDes has evolved to incorporate two types of constraints to guide the design
process: topological and functional. The former entails the fragments to assemble the protein
structure and sets of spatial constraints that bias the folding trajectories towards a desired
topology; and the latter are the structure of the functional motif and the binding target.
Our methodological approach fills the gap between conservative grafting approaches where
the structure of the host scaffold is mostly fixed (Rosetta Epigraft and Motifgraft [19, 52]) and
the full de novo assembly of non-predefined protein topologies bearing functional motifs [53,
54]. FunFolDes lies in between, by affording considerable structural flexibility to the host scaf-
fold within the boundaries of its topology. In our view, FunFolDes is the most appropriate tool
in situations where the structural mimicry of the functional motif is distant from the receiving
scaffold’s site and overall conformational adaptations are necessary to design viable protein
structures and sequences.
We have extensively benchmarked FunFolDes, leveraging natural structural and sequence
variation of proteins within the same fold, as well as deep mutational scanning data for the
computationally designed protein BINDI [21]. In our first benchmark, we observed that Fun-
FolDes biases the sampling towards improved structural and sequence spaces. Improved sam-
pling may contribute to solve some of the major limitations in protein design, related to “junk”
sampling, where many designs are not physically realistic, exhibiting flaws according to gen-
eral principles of protein structure. Importantly, higher quality sampling will likely contribute
to improve the success rate of designs that are tested experimentally. The BINDI benchmark
allowed us to test FunFolDes in a system with extensive experimental data, which included
both sequences and structures. Perhaps the most interesting observation was that designs that
were theoretically within a sequence/structure space productive for binding, were far from the
energetic minimum accessible to the protein fold in the absence of the binding target. This
observation resembles the stability-function tradeoffs that have been reported from in vitro
evolution experimental studies [44, 45]. The large majority of the design algorithms are energy
“greedy” and the sequence/structure searches are performed with the central objective of find-
ing the global minimum of the energetic landscape. By introducing functional constrains into
the simulations, FunFolDes presents an alternative way of designing functional molecules and
skew the searches towards off-minima regions of the global landscape. We anticipate that such
finding will be more relevant for protein scaffolds that need to undergo a considerable struc-
tural adaptation to perform the desired function. If confirmed that this finding is generalized
across multiple design problems, it could be an important contribution for the field of compu-
tational protein design.
Furthermore, we used FunFolDes to tackle two design challenges and functionalized two
proteins with two distinct viral epitopes generating synthetic proteins that could have impor-
tant translational applications in the field of vaccine development. In previous applications,
FFL always used three-helix bundles as design templates, here we diversified the template folds
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and used an all-helical protein that is not a bundle (1kx8) and a mixed alpha-beta protein
(TOP7), clearly demonstrating the applicability to other folds. For the 1kx8 design series, we
evaluated the capability of using distant structural templates as starting topologies as a demon-
stration of how to functionally repurpose many naturally occurring protein structures avail-
able. We obtained stable proteins that were recognized by an anti-RSV antibody with high
affinity, showing that in this case, we successfully repurposed a distant structural template for
a different function, a task for which other computational approaches [55] would have limited
applicability. We see this result as an exciting step forward towards using the wealth of the nat-
ural structural repertoire for the design of novel functional proteins.
In a last effort, we functionalized a “functionless” fold, based on one of the first de novo
designed proteins–TOP7. For us, this challenge has important implications to understand the
design determinants and biochemical consequences of inserting a functional motif into a pro-
tein that was mainly optimized for thermodynamic stability. We were successful in functiona-
lizing TOP7 differently than previous published efforts. Previously, TOP7 was mostly used as a
carrier protein with functional motifs fused onto loop regions or side chains grafted in the heli-
cal regions [22, 50, 51], while our functional motif was embedded in the beta-sheet region.
Exciting advances in the area of de novo protein design are also yielding many new proteins
[11–13], which could then be functionalized with FunFolDes, highlighting the usefulness of
this approach. Interestingly, we observed that the functionalized version of TOP7 showed a
dramatic decrease in thermodynamic stability as compared to the parent protein. While this
observation can be the result of many different factors, it is compelling to interpret it as the
“price of function”, meaning that to harbor function, TOP7 was penalized in terms of stability,
which would be consistent with our findings in the BINDI benchmark and the experimental
studies on stability-function tradeoffs.
Recently, there have also been several de novo proteins designed for functional purposes
[56]; however, these efforts were limited to linear motifs that carried the functions, and the
functionalization was mainly accomplished by side-chain grafting [3, 5], relying on screening
a much larger number of designed proteins.
In the light of all the technical improvements, FunFolDes has matured to become a valuable
resource for the robust functionalization of proteins using computational design. Here, we
presented a number of important findings provided by the detailed benchmarks performed
and used the protocol to functionalize proteins in design tasks that are representative of com-




Rosetta Functional Folding and Design (FunFolDes) is a general approach for grafting func-
tional motifs into protein scaffolds. It’s main purpose is to provide an accessible tool to tackle
specifically those cases in which structural similarity between the functional motif and the
insertion region is low, thus expanding the pool of structural templates that can be considered
useful scaffolds. This objective is achieved by folding the scaffold after motif insertion while
keeping the structural motif static. This process allows the scaffold’s conformation to change
and properly adapt to the three-dimensional restrictions enforced by the functional motif. The
pipeline of the protocol (summarized in Fig 1) proceeds as follows:
Selection of the functional motif. A single or multi-segment motif must be selected and
provided as an input. In the most common mode of the protocol, dihedral angles, side chain
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identities and conformations are kept fixed throughout the whole protocol. Conserved
sequence length between the motif and the insertion region is not required.
Selection of the protein scaffold. Searches for starting protein scaffolds can be achieved,
but are not limited to, RMSD similarity matches to the Protein Data Bank (PDB) [57]. The
ability of FunFolDes to adapt the scaffold to the needs of the motif widens the structural space
of what can be considered a suitable template. Thus, this step requires human intervention
and is performed outside of the main protocol.
Generation of fragment databases. The usage of fragments lies at the core of many
Rosetta protocols, particularly those that perform large explorations of the conformational
space required for structure prediction and design. The most standard way of assembling frag-
ment sets is to generate sequence-based fragments using the FragmentPicker application [39].
While sequence-based fragments are critical in structure prediction problems, FunFolDes
designs have a higher dependency from the structural content of the template rather than its
sequence. Thus, we implemented the StructFragmentMover, a mover that performs on-the-fly
fragment picking based on secondary structure, dihedral angles and solvent accessibility, cal-
culated from the template’s structural information. The typical three- and nine residue-long
fragment sets are generated from the global fragment database included in the Rosetta tools
release.
Generation of constraints. Residue-pair distance and backbone dihedral angle con-
straints can be extracted from the protein scaffold to guide the folding process. These con-
straints may include the full-length protein or focus in specific segments while allowing a
wider flexibility in other regions. Although not required, the use of constraints greatly
increases the quality of the sampling. The protocol can be also made aware of other constraint
types (such as cartesian constraints) by properly modifying the score functions applied to the
ab initio stage [58].
Construction of the extended pose. The extended structure is composed of all the seg-
ments of the target motif maintaining their native backbone conformation and internal rigid
body orientation. The scaffold residues are linearly attached to previously defined insertion
points. In multi-segment motif scenarios, the construct will present a chain break between
each of the motif-composing segments. This also allows for the segments to be placed into the
design in non-consecutive sequence order. Details on how these chain breaks are created can
be found in S1 Text. Once the extended pose is assembled, it is represented at the centroid
level (all side-chain atoms in a single virtual atom) to reduce the computational cost of the
simulation.
Folding the extended pose. Fragment insertion is performed to accomplish the folding
stage. Kinematics of the pose are controlled through the FoldTree [59], a system to control the
propagation of the torsion angles applied to a structure. The procedure on how the FoldTree is
build and exploited to maintain the appropriate position between different segments of the
functional motif is detailed in S1 Text. By default, the folding stage is allowed 10 trials to gen-
erate a decoy bellow a user defined RMSD threshold. In case the threshold is not reached, this
trajectory is skipped and no design will be output.
Inclusion of the binding target. If a binding target (protein, nucleic acid or small mole-
cule ligand) is provided, a new FoldTree node is added to the closest residue between the first
motif segment and each binding element. Similarly to the multi-segment kinematics, this
ensures that the rigid-body orientation between the motif and its target is maintained. Fun-
FolDes can handle simulations with both multi-segment and binding targets simultaneously.
Folding post-processing. Folding trajectories are considered successful if they generate
structures under a user-defined RMSD threshold of the starting scaffold. In case of a multi-seg-
ment motif, a preliminary loop closure will be executed to generate a continuous polypeptide
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chain, and the kinematic setup maintained to avoid segment displacement during the design
step. After the centroid folding stage, the full atom information pose is recovered. All the steps
necessary to perform the setup of the extended pose (kinematic setup, folding, post-process-
ing) are carried out by a newly implemented mover called NubInitioMover.
Protein design and conformational relaxation. The folded structure is subjected to itera-
tive cycles of sequence design [60] and structural relaxation [61] in which the sequence search
is coupled with confined conformational sampling [62]. A MoveMap is defined to control
backbone dihedrals and side chain conformations of the motif segments and the binding target
while allowing for backbone and side-chain sampling of the movable residues (S1 Text). Tas-
kOperations are used to avoid undesired mutations in the functional motif.
Loop closure. If multi-segment motifs are used, a final loop closure step is required in
order to obtain a polypeptide chain without breaks. The NubInitioLoopClosureMover performs
this last step using the Cyclic Coordinate Descend (CCD) protocol [59], while ensuring that
the original conformation and rigid-body orientation of the motifs is maintained. After the
closure of each cut-point, a final round of fixed backbone design is performed on the residues
of the cut-points and surroundings.
Selection, scoring and ranking. Finally, the decoys are ranked and selected according to
Rosetta energy, structural metrics (core packing, buried unsatisfied polar atoms, etc) [63],
sequence-based predictions such as secondary structure propensity [64] and folding propen-
sity [58] or any other metrics accessible through RosettaScripts (RS). For the in silico bench-
marks and the design assessments in this work, we used the rstoolbox [65] to produce the
statistical analysis and select the best-ranked decoys.
The pipeline components described here represent the most standardized version of the
FunFolDes protocol. By means of its integration in RS, different stages can be added, removed
or modified to tailor the protocol to the specific needs of the design problem at hand.
Capturing conformational and sequence changes in small protein domains
To test the ability of FunFolDes to recover the required conformational changes to stabilize a
given structural motif, we created a benchmark of 14 target cases of proteins with less than 100
residues, named T01 to T14. Each target case was composed of two structures of the same
CATH superfamily [38]. One of the structures was representative of the shared structural fea-
tures of the CATH family; we called this structure the reference. The second protein within
each target case can present two types of structural variations with respect to the reference: I)
an insertion or deletion (indel) region and II) a conformational change. Direct structural con-
tacts between these two regions make it so that the indel region is likely the cause for the con-
formational change. We called this second structure the target (Fig 2, Table 1).
For each template protein we generated approximately 10000 decoys with FunFolDes by fold-
ing the target with the following conditions: 1) the indel region was considered as the motif,
meaning that its structural conformation was kept fixed and no mutations allowed; 2) residue-
pair distance constraints were derived from the secondary structure elements conserved between
reference and the target (constrained region); 3) the region of the protein which showed the larg-
est structural variations (query region) was constraint-free throughout the simulation.
FunFolDes simulations were compared with constrained ab initio (cst-ab initio) simula-
tions, the key difference being that the cst-ab initio simulations allowed for backbone flexibility
in the motif region. The comparison between both approaches provides insights on the effects
of a static segment in the folding trajectory of the polypeptide chain. In both scenarios a
threshold was set after the folding stage where only decoys that had less than 5 Å RMSD from
the template were carried to the design stage.
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The importance of the input fragments was assessed in our benchmark. Both protocols
were tested with sequence-based fragments from FragmentPicker and structure-based frag-
ments generated on-the-fly by FunFolDes. Comparison between the two types of fragments
provides insight into how to utilize FunFolDes in the most productive manner.
Structural recovery was evaluated by RMSD with the target structure. Global RMSD, under-
stood as the minimum possible RMSD given the most optimal structural alignment, was used
to assess the overall structural recovery of each decoy population. Local RMSD, was evaluated
for the unconstrained (query) region and the motif by aligning each decoy to the template
through the constrained segments (excluding the motif). This metric aimed to capture the spe-
cific conformational changes required to accommodate the motif into the structure (Fig 2B,
S1B Fig).
Sequence recovery was evaluated through two different criteria, sequence associated statis-
tics and Hidden Markov Model (HMM) [41]. For the sequence associated statistics, we quanti-
fied sequence identity and similarity according to BLOSUM62 for the core residues of each
protein, as defined by Rosetta’s LayerSelector [7]. Motif residues, that were not allowed to
mutate, were excluded from the statistics. In the second criteria, position specific scoring
matrices with inter-position dependency known as Hidden Markov Model (HMM) were used
to evaluate fold specific sequence signatures. In this case, the closest HMM to the template
structure provided by CATH was used to query the decoys and identify those that matched the
HMM under two conditions: I) an e-value under 10 and II) a sequence coverage over 50%.
Although these conditions are wide, they were within the ranges found between members of
CATH superfamilies with high structural and sequence variability like the ones used in the
benchmark.
Target-biased design of protein binders
To assess the performance of FunFolDes in the presence of a binding target we recreated the
design of BINDI as a binder for BHRF1 [21], the BHRF1 binding motif from the BIM-BH3
protein (PDB ID:2WH6 [66]) was inserted into a previously described 3-helix bundle scaffold
(PDB ID:3LHP [3]).
Table 1. Targets included in the conformational and sequence recovery benchmark. For each of the benchmark targets is indicated the CATH superfamily and repre-
sentatives used in the simulations. (#) indicates the number of segments in the target protein that are considered motif. Motif range indicates the residues considered motif
according to the PDB numbering.
ID CATH # reference target motif range
T01 CATH.3.40.140.10 1 1pgxA 2pw9C 69–73
T02 CATH.3.30.310.50 1 3i3wA 4bjuA 464–486
T03 CATH.3.30.70.980 1 1lfpA 1mw7A 140–150
T04 CATH.3.30.70.100 1 1rjjA 1lq9A 19–45
T05 CATH.3.10.20.30 1 2q5wD 2pkoA 49–64
T06 CATH.2.30.29.30 1 1c1yB 1h4rA 39–59
T07 CATH.3.10.20.90 1 2bkfA 2al6B 115–119
T08 CATH.3.10.20.90 1 1wj4a 1wiaA 181–200
T09 CATH.3.10.20.90 1 3ny5B 3phxB 100–121
T10 CATH.3.10.20.310 1 2x8xX 2qdfA 103–121
T11 CATH.3.10.320.10 1 4p5mA 2bc4C 56–66
T12 CATH.2.40.40.20 1 1cr5B 2pjhB 119–142
T13 CATH.2.40.40.20 2 1cr5B 2pjhB 119–142, 168–173
T14 CATH.3.30.110.40 1 1jdqA 3lvjC 14–37
https://doi.org/10.1371/journal.pcbi.1006623.t001
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Four different design simulations were performed, one without the binder (no_target) and
three in the presence of the binder (static, pack and packmin). The difference between the last
three relates to how the binding target was handled. In the static simulations the binding target
was kept fixed and no conformational movement in the side chains was allowed throughout
the protocol. In the pack simulations the side chains of the binding target were repacked dur-
ing the binder design stage. Finally, in the packmin simulations the binding target side-chains
were allowed to repack and both side-chains and backbone were subjected to minimization. In
all cases, the two terminal residues on each termini of the binding motif were allowed back-
bone movement to optimize the insertion in the 3-helix bundle scaffold. For each of these sim-
ulations, approximately 20000 decoys were generated.
For the no_target simulations the FunFolDes designs were docked to BHRF1 using the
inserted motif as guide to assess their complementarity and interface metrics. In all the simula-
tions, a final round of global minimization was performed, where both proteins of the complex
were allowed backbone flexibility. During this minimization, the rigid-body orientation
between the design and target was kept fixed. The final ΔΔG of the complexes was measured
after the minimization step to enable comparisons between the no_target decoys and the
remaining simulation modes. Structural changes related to this minimization step were evalu-
ated as the global RMSD between each structure before and after the process, this measure is
referred to as RMSD drift.
Structural evaluation includes global RMSD against the BINDI crystal structure (PDB ID:
4OYD [21]) as well as local RMSDs against regions of interest in BINDI. In the Local-RMSD
calculations the structures were aligned through the inserted motif, as its conformation and ori-
entation relative to BINDI were kept fixed throughout all simulations. The local RMSD analysis
was performed over all the helical segments contained in the structures (all H), which provided
a measurement of the structural shifts on the secondary structure regions of the designs.
To evaluate the sequence recovery we leveraged BINDI’s saturation mutagenesis data ana-
lyzed by deep sequencing performed by Procko et al [21]. The experimental fitness of each
mutation was summarized in a score matrix where a score was assigned to each amino-acid
substitution for the 116 positions of the protein (S2C Fig). In summary, point mutations that
improved BINDI’s binding to BHRF1 are assigned positive scores while deleterious mutations
present negative values. These scores were computed based on experimental data where the
relative populations of each mutant were compared between a positive population of cells dis-
playing the designs (binders) and negative populations (mutants that display but don’t bind),
these experiments have been described in detail elsewhere [21]. Upon normalization by the
BINDI sequence score, a position sequence specific matrix (PSSM) was created. Like the origi-
nal data, this matrix also assigns a positive score to each point mutation if it resulted in an
improved binding for the design. This normalization provides a score of 0 for the BINDI
sequence, which is useful as a reference score.
Repurposing naturally occurring folds for a new functions
To experimentally validate the capabilities of FunFolDes and insert functional sites in structur-
ally distant templates, we grafted the 11 residues from the site II epitope from the Respiratory
Syncytial Virus (RSV) protein F (PDB ID:3IXT [46]), residues 256 to 276 in chain P (NSELL-
SLINDMPITNDQKKLMSN), into heterologous scaffolds. This is a continuous, single seg-
ment, helix-loop-helix conformation epitope. The main objective was to challenge the
capabilities of FunFolDes to reshape the structure of the scaffold to the requirements of the
functional motif. We searched for insertion segments with RMSDs towards the site II structure
higher than 2 Å.
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The structural searches were performed using MASTER [47] where we used the full-length
site II segment as a query against a subset of 17539 protein structures from the PDB, composed
of 30% non-redundant sequences included in the MASTER distribution. The RMSD between
the query and segments on the scaffolds were assessed using backbone Cαs. All matches with
RMSDCα< 5.5 Å relative to site II were further filtered by protein size, where only proteins
between 50 and 100 residues were kept. These scaffolds were then ranked regarding antibody-
binding compatibility, where each match was realigned to the antibody–epitope complex and
steric clashes between all glycine versions of the scaffold and antibody were quantified using
Rosetta. All matching scaffolds with ΔΔG values above 100 REU were discarded under the
assumption that their compatibility with the antibody binding mode was too low. The remain-
ing scaffolds were visually inspected and PDB ID: 1kx8 [48] (RMSDCα = 2.37 Å) was selected
for design with FunFolDes. The twenty-one residues from the site II epitope (motif) as present
in 3IXT were grafted into a same sized segment (residues 79–100) of 1kx8 using the NubInitio-
Mover. Up to three residues in each insertion region of the motif were allowed backbone flexi-
bility in order to model proper conformational transitions in the insertion points. Atom pair
constraints with a standard deviation of 3 Å were defined for all template residues, leaving the
motif segment free of constraints. The generous standard deviation was defined to allow for
necessary conformational changes to retrofit the motif within the topology. The total allowed
deviation from the template was limited to 5 Å to ensure the retrieval of the same topology.
In this design series we used sequence-based fragments generated with the 1kx8 native
sequence. Three cycles of design/relax were performed on the template residues with the
FastDesignMover.
A first generation of 12500 designs was ranked according to Rosetta energy. From the top
50 decoys, only one presented the motif without distortions on the edges derived from the
allowed terminal flexibility. This decoy was used as template on the second generation of Fun-
FolDes to enhance the sampling of properly folded conformations, with the same input condi-
tions as before.
In the second generation, the top 50 decoys according to Rosetta energy were further opti-
mized through additional cycles of design/relax. The final designs were again selected using a
composite filter based on Rosetta energy (top 50), buried unsatisfied polar atoms (<15), cavity
volume (< 75 Å3) and we obtained a final set of 15 candidates from which we prioritized 6
upon the inspection of the computational models. In addition, we also quantified the secondary
structure prediction using PSIPRED [64], all the tested designs had more 65% (ranging from
65% to 92%) of the residues with correct secondary structure prediction. The final designs were
manually optimized, this process entailed the removal of designed hydrophobic residues in sol-
vent exposed positions, in this designs series we performed between 2 and 4 mutations obtain-
ing 7 designs from the previous 6. After the initial characterization, designs with added disulfide
bridges were generated to improve protein stability and affinity (S3 Fig, S4 Fig). To do so, we
use the Rosetta DisulfidizeMover, which screened the designed models for pairs of residues with
favourable three-dimensional orientations to host disulfide bonds. Upon the placement of the
disulfide bond, the neighbouring residues within 10 Å of the disulfide, were designed to opti-
mize the residue interactions and improve the packing of the designed region.
Functionalization of a functionless fold
In a second effort to test the design capabilities of FunFolDes we sought to insert a functional
motif in one of the first de novo designed proteins–TOP7 (PDB ID: 1QYS [13])
Six residues from the complex between the antibody 101F and the peptide-epitope, corre-
sponding to residues 429–434 in chain P (RGIIKT) on the full-length RSV F protein [49], were
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grafted into the edge strand of the TOP7 backbone using FunFolDes. The choice between epi-
tope and hosting scaffold was made based on the secondary structure adopted by the epitope
and the structural compatibility of TOP7, the RMSDCα between the epitope an the insertion
segment was 2.07 Å.
To ensure that the majority of the β-strand secondary structure was maintained throughout
the grafting protocol, the epitope motif was extended by one residue and a designed 4-residue
β-strand (KVTV) pairing with the backbone of the C-terminal epitope residues was co-grafted
as a discontinuous segment into the adjacent strand of the TOP7 backbone. With this strategy
we circumvented a Rosetta sampling limitation, where often times extensive sets of constraints
to achieve backbone hydrogen-bonds on beta-strands are necessary [8]. After defining the
motif consisting of the epitope plus the pairing strand and the sites of insertion on the TOP7
scaffold, FunFolDes was used to graft the motif.
Backbone flexibility was allowed for the terminal residues of the functional motif and a β-
turn connection between the two strands was modelled during the folding process (NubInitio-
Mover). During the folding process, the 101F antibody was added to the simulation in order to
limit the explored conformational space productive for binding. Finally, the NubInitioLoop-
ClosureMover was applied to ensure that a proper polypeptide chain was modelled and no
chain-breaks remained, a total of 800 centroid models were generated after this stage. Next, we
applied an RMSD filter to select scaffolds with similar topology to TOP7 (< 1.5 Å) and a
hydrogen bond long-range backbone score (HB_LR term) to favour the selection of proteins
with proper beta-sheet pairing. The top 100 models according the HB_LR score and<1.5 Å to
TOP7, were then subjected to an iterative sequence-design relax protocol, alternating fixed
backbone side-chain design and backbone relaxation using the FastDesignMover. Two differ-
ent design strategies were pursued: I) partial design—amino acid identities of the C-terminal
half of the protein (residues 45 through 92) were retained from TOP7 while allowing repacking
of the side chains and backbone relaxation; II) full-design—the full sequence space in all resi-
dues of the structure (with the exception of the 101F epitope) was explored. No backbone or
side chain movements were allowed in the 6-residue epitope segment whereas the adjacently
paired β-strand was allowed to both mutate and relax. Tight Cα atom-pair distance constraints
(standard deviation of 0.5 Å) were used to restrain movements of the entire sheet throughout
the structural relaxation iterations.
From the 100 designs generated, only those that passed a structural filter requiring 80%
beta-sheet secondary structure composition after backbone relaxation were selected for further
analysis.
The 93 designs passing this filter were evaluated with a composite filter based on REU score
(Top 50), hydrogen-bond long-range backbone interactions (< -113) and core packing
(> 0.7). The selected designs were finally submitted to human-guided optimisation to correct
for hydrophobic residues that were designed in solvent exposed positions (1–3) and shortening
of the connecting loop between the two inserted strands using the Rosetta Remodel application
[67].
Interestingly, in an attempt to reproduce the same grafting exercise with MotifGraftMover
[55], this resulted in non-resolvable chain breaks when trying to graft either the two segment-
motif or the epitope alone into the TOP7 scaffold.
Protein expression and purification
DNA sequences of the designs were purchased from Twist Bioscience. For bacterial expression
the DNA fragments were cloned via Gibson cloning into a pET21b vector containing a C-ter-
minal His-tag and transformed into E. coli BL21(DE3). Expression was conducted in Terrific
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Broth supplemented with ampicillin (100 μg/ml). Cultures were inoculated at an OD600 of 0.1
from an overnight culture and incubated at 37˚C with a shaking speed of 220 rpm. After reach-
ing OD600 of 0.7, expression was induced by the addition of 1 mM IPTG and cells were further
incubated for 4-5h at 37˚C. Cells were harvested by centrifugation and pellets were resus-
pended in lysis buffer (50 mM TRIS, pH 7.5, 500 mM NaCl, 5% Glycerol, 1 mg/ml lysozyme, 1
mM PMSF, 1 μg/ml DNase). Resuspended cells were sonicated and clarified by centrifugation.
Ni-NTA purification of sterile-filtered (0.22 μm) supernatant was performed using a 1 ml His-
Trap FF column on an A¨KTA pure system (GE healthcare). Bound proteins were eluted using
an imidazole concentration of 300 mM. Concentrated proteins were further purified by size
exclusion chromatography on a Superdex 75 300/10 GL or a Hiload 16/600 Superdex 75 pg
column (GE Healthcare) using PBS buffer (pH 7.4) as mobile phase.
For IgG expression, heavy and light chain DNA sequences were cloned separately into pFU-
SE-CHIg-hG1 (InvivoGen) mammalian expression vectors. Expression plasmids were co-
transfected into HEK293-F cells in FreeStyle medium (Gibco) using polyethylenimine (Poly-
sciences) transfection. Supernatants were harvested after 1 week by centrifugation and purified
using a 5 ml HiTrap Protein A HP column (GE Healthcare). Elution of bound proteins was
accomplished using a 0.1 M glycine buffer (pH 2.7) and eluents were immediately neutralized
by the addition of 1 M TRIS ethylamine (pH 9). The eluted IgGs were further purified by size
exclusion chromatography on a Superdex 200 10/300 GL column (GE Healthcare) in PBS
buffer (pH 7.4). Protein concentrations were determined by measuring the absorbance at 280
nm using the sequence calculated extinction coefficient on a Nanodrop (Thermo Scientific).
Circular Dichroism (CD)
Far-UV circular dichroism spectra of designed scaffolds were collected between a wavelength
of 190 nm to 250 nm on a Jasco J-815 CD spectrometer in a 1 mm path-length quartz cuvette.
Proteins were dissolved in PBS buffer (pH 7.4) at concentrations between 20 μM and 40 μM.
Wavelength spectra were averaged from two scans with a scanning speed of 20 nm min-1 and a
response time of 0.125 sec. The thermal denaturation curves were collected by measuring the
change in ellipticity at 220 nm from 20 to 95˚C with 2 or 5˚C increments.
Size-exclusion Chromatography combined with Multi-Angle Light-
Scattering (SEC-MALS)
Multi-angle light scattering was used to assess the monodispersity and molecular weight of the
proteins. Samples containing between 50–100 μg of protein in PBS buffer (pH 7.4) were
injected into a Superdex 75 300/10 GL column (GE Healthcare) using an HPLC system (Ulti-
mate 3000, Thermo Scientific) at a flow rate of 0.5 ml min-1 coupled in-line to a multi-angle
light scattering device (miniDAWN TREOS, Wyatt). Static light-scattering signal was recorded
from three different scattering angles. The scatter data were analyzed by ASTRA software (ver-
sion 6.1, Wyatt)
Surface Plasmon Resonance (SPR)
To determine the dissociation constants of the designs to the mota or 101F antibodies, surface
plasmon resonance was used. Experiments were performed on a Biacore 8K at room tempera-
ture with HBS-EP+ running buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 3mM EDTA,
0.005% v/v Surfactant P20) (GE Healthcare). Approximately 1200 response units of mota or
101F antibody were immobilized via amine coupling on the methyl-carboxyl dextran surface
of a CM5 chip (GE Healthcare). Varying protein concentrations were injected over the surface
at a flow rate of 30 μl/min with a contact time of 120 sec and a following dissociation period of
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400 sec. Following each injection cycle, ligand regeneration was performed using 3 M MgCl2
(GE Healthcare). Data analysis was performed using 1:1 Langmuir binding kinetic fits within
the Biacore evaluation software (GE Healthcare).
Availability
FunFolDes is available as part of the Rosetta software suite and is fully documented in the
Rosetta Commons documentation website as one of the Composite Protocols. All data and
scripts necessary to recreate the analysis and design simulations described in this work are
available at https://github.com/lpdi-epfl/FunFolDesData.
Supporting information
S1 Text. FoldTree and MoveMap. Description of the specific setup of the FoldTree and Move-
Map in order to properly guide the folding process in FunFolDes.
(PDF)
S1 Fig. Structural composition and overall results of the benchmark targets. A) Percentage
of secondary structure type, motif and query region in the overall structures. B) Full structure
RMSD (Overall RMSD) and local RMSD for the query region (Query Region) between the
decoy populations and their respective targets. FunFolDes tends to outperform cst–ab initio in
all scenarios and the structure-based fragments yield decoy population with lower mean
RMSDs, albeit with small differences relative to the sequence-based fragments.
(TIF)
S2 Fig. Target-biased folding and design: Structural features of the modeled designs and
saturation mutagenesis data used for sequence recovery benchmark. A) Quantification of
the percentage of decoys compatible with a design-target binding conformation for the differ-
ent simulation modes. The simulations performed without the target yield a very low percent-
age of binding compatible conformations. After minimization, this percentage increases with
significant structural drifts. B) The initial template is a 3-helix bundle structure, the slight shift
needed to adopt a binding-compatible conformation produces only a small global RMSD. C)
Graphical representation of the deep-sequencing data as a position-specific score matrix.
Black borders highlight the native BINDI residue type for each position. Mutations for which
no data were obtained, likely reflect that these protein variants were unable to fold or display at
the surface of yeast and were assigned the lowest score of -5.
(TIF)
S3 Fig. Structural and sequence evaluation of the computational designs. Assessment of
structural and sequence features: Rosetta Energy, packing score (packstat) [63], cavity volume,
Buried UNSatisfied polar atoms and secondary structure prediction (PSIPRED) for the tem-
plate and the computational designs. Each native template (green diamond and vertical dashed
line) and design (yellow and blue circles) are compared against a set of non-redundant mini-
mized structures of similar size (± 15 residues). A) Due to its natural function, 1kx8 presents
of a large cavity to bind its hydrophobic ligands. As such, the structure presents generally low
scores as compared to computationally designed proteins. B) Distributions of the structural
and sequence features of natural proteins and the TOP7 series of designs.
(TIF)
S4 Fig. Examples of experimental characterization performed for other variants on the
1kx8 design series. A) CD wavelength spectra (left column), thermal denaturations (middle
column) and SPR binding assays with the mota antibody (right column) were performed. B)
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Global sequence alignment of the wild-type protein 1kx8 and the computationally designed
sequences. Red positions highlight the site II epitope insertion. Green positions highlight the
cysteines performing the disulfide bridges. The two positions that consistently kept the original
residue type of 1kx8 are highlighted in bold.
(TIF)
S5 Fig. In silico assessment of 1kx8_d2 and TOP7_full computational designs. A) Ab initio
folding simulations for wild-type 1kx8 (left) and design 1kx8_d2 (center), ensembles generated
by relaxing the starting structures are shown in orange. The inability of 1kx8 to form a proper
folding funnel could be explained by the big internal cavity of the protein due to its fatty-acid
binding pocket. Docking-minimization simulations (right) performed with the top50 scoring
ab initio decoys. The docking simulations reveal a similar binding configuration between the
peptide motif and the full design, and ΔΔGs are within a similar range to those of the native
peptide antibody complex. B) Same simulations as described in A) for wild-type TOP7 (left)
and TOP7_full (center). We observe energetically favorable folding funnels for both wildtype
and design. The docking simulations showed that the complex between the design and the
antibody is formed in a similar structural configuration to the peptide-antibody complex
achieving a similar range of ΔΔGs.
(TIF)
S6 Fig. Experimental characterization of TOP7_variants. A) Experimental characterization
for the TOP7_partial design: SEC-MALS elution profile (left column); CD wavelength scan
spectrum; SPR binding assays with the 101F antibody (right column). The TOP7_partial CD
spectrum is notably different from WT TOP7 and the TOP7_full design. B) Global sequence
alignment of the wild-type protein TOP7 and the computationally designed sequences. Red
positions highlight the site IV epitope insertion.
(TIF)
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